Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils. Attenuation of p47phox and p67phox membrane translocation as the mechanism.
Open Access
- 1 December 1995
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 96 (6) , 2654-2660
- https://doi.org/10.1172/jci118331
Abstract
Surfactant has been shown to inhibit the production of reactive oxygen intermediates by various cells including alveolar macrophages and peripheral blood neutrophils. Superoxide O2-. production by the respiratory burst oxidase in isolated plasma membranes prepared from PMA-treated human neutrophils was significantly attenuated by prior treatment with native porcine surfactant. The effect was concentration dependent with half-maximal inhibition seen at approximately 0.050 mg surfactant phospholipid/ml. Kinetic analyses of the membrane-bound enzyme prepared from neutrophils stimulated by PMA in the presence or absence of surfactant demonstrated that surfactant treatment led to a decrease in the maximal velocity of O2-. production when NADPH was used as substrate, but there was no effect on enzyme substrate affinity. Immunoblotting studies demonstrated that surfactant treatment induced a decrease in the association of two oxidase components, p47phox and p67phox, with the isolated plasma membrane. In contrast, surfactant treatment of the cells did not alter the phosphorylation of p47phox. A mixture of phospholipids (phosphatidylcholine and phosphatidylglycerol in a 7:3 ratio) showed similar inhibition of the PMA-induced O2-. generation. Taken together, these data suggest the mechanism of surfactant-induced inhibition of O2-. production by human neutrophils involves attenuation of translocation of cytosolic components of the respiratory burst oxidase to the plasma membrane. The phospholipid components of surfactant appear to play a significant role in this mechanism.Keywords
This publication has 44 references indexed in Scilit:
- Safety and Potential Efficacy of an Aerosolized Surfactant in Human Sepsis-Induced Adult Respiratory Distress SyndromeJAMA, 1994
- Pulmonary Surfactant Protein A Enhances the Host-defense Mechanism of Rat Alveolar MacrophagesAmerican Journal of Respiratory Cell and Molecular Biology, 1990
- Pulmonary Surfactant Inhibits Priming of Rabbit Alveolar Macrophage: Evidence that Surfactant Suppresses the Oxidative Burst of Alveolar Macrophage in Infant RabbitsAmerican Review of Respiratory Disease, 1989
- Evaluation of protein phosphorylation state by a combination of vertical slab gel isoelectric focusing and immunoblottingAnalytical Biochemistry, 1989
- Recombinant 47-Kilodalton Cytosol Factor Restores NADPH Oxidase in Chronic Granulomatous DiseaseScience, 1989
- Use of an Affinity Label to Probe the Function of the NADPH Binding Component of the Respiratory Burst Oxidase of Human NeutrophilsJournal of Biological Chemistry, 1989
- Surfactant therapy of newborn rabbits impairs lung macrophage bactericidal activityJournal of Applied Physiology, 1988
- The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein.Journal of Biological Chemistry, 1987
- CHARACTERISTICS OF PULMONARY SURFACTANT IN ADULT RESPIRATORY-DISTRESS SYNDROME ASSOCIATED WITH TRAUMA AND SHOCKPublished by Elsevier ,1977
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970